Frankfurt - Delayed Quote EUR
Gossamer Bio, Inc. (4GB.F)
0.7645
+0.0750
+(10.88%)
As of 3:29:01 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,468
-3,468
-159,158
-187,032
-188,890
Investing Cash Flow
29,023
29,023
-110,970
-1,035
-117,427
Financing Cash Flow
-11,488
-11,488
190,154
117,090
3,329
End Cash Position
46,074
46,074
32,109
111,973
183,467
Interest Paid Supplemental Data
10,561
10,561
12,288
12,712
12,738
Capital Expenditure
--
--
--
-475
-1,621
Issuance of Capital Stock
--
--
201,323
119,946
--
Repayment of Debt
-12,581
-12,581
-11,613
-5,806
--
Free Cash Flow
-3,468
-3,468
-159,158
-187,507
-190,511
12/31/2021 - 2/13/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AAGH America Great Health
0.0050
0.00%
SANN.SW Santhera Pharmaceuticals Holding AG
14.34
-1.38%
ASMB Assembly Biosciences, Inc.
10.45
+0.38%
GLYC GlycoMimetics, Inc.
0.2518
+5.49%
TARA Protara Therapeutics, Inc.
4.1600
-0.95%
SKYE Skye Bioscience, Inc.
1.7121
-1.03%
MREO Mereo BioPharma Group plc
2.4950
-2.54%
TLSA Tiziana Life Sciences Ltd
1.4305
+9.20%
STRO Sutro Biopharma, Inc.
0.8527
-5.26%
SLS SELLAS Life Sciences Group, Inc.
1.3350
+1.91%